- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
NanoVibronix Announces Selection of Leading International Contract Manufacturer
NanoVibronix (NASDAQ:NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has appointed Quasar as its contract manufacturer for the PainShield, UroShield, WoundShield as well as other devices. As quoted in the press release: Quasar (http://www.quasar-med.com/) is a medical device manufacturer with over 30 years of …
NanoVibronix (NASDAQ:NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has appointed Quasar as its contract manufacturer for the PainShield, UroShield, WoundShield as well as other devices.
As quoted in the press release:
Quasar (https://www.quasar-med.com/) is a medical device manufacturer with over 30 years of experience, serving major brands worldwide, with complex catheters, disposables, and FDA regulated assemblies. Quasar delivers a full lifecycle array of engineering services, including design-to-cost, jigs and tool design, as well as unique production process-design services that allow for the highest levels of efficiency and productivity. Quasar is ISO9001 and ISO13485 certified, as well as FDA registered.
Brian Murphy, Chief Executive Officer of NanoVibronix, commented, “We are delighted to announce the timely selection of Quasar as we begin our commercial ramp-up. Quasar brings decades of medical device manufacturing experience in China with on-site western ownership and management. Their turnkey solutions include supply chain management, production and quality engineering, manufacturing, testing and logistics. They have a demonstrated track record working with leading medical device companies and the ability to ensure high quality, high volume production to support our aggressive growth plans. By outsourcing manufacturing, we expect to generate meaningful cost savings, which should allow us to lower our selling price, increase production to meet revenue expectations, open additional markets, and improve profitability.”
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.